About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Radioligand Therapy Market Size, Demand, Opportunities, Forecast by 2033
Radioligand Therapy Market
Radioligand Therapy Market

Radioligand Therapy Market Size, Share & Trends Analysis Report By Isotope (Lutetium-177 (Lu-177), Actinium-225 (Ac-225), Iodine-131 (I-131), Other Isotopes), By Target (Prostate-Specific Membrane Antigen, Ki 67 Expression and Grading, Cytochrome P450 17A1 Inhibitor), By Indication (Prostate Cancer, Neuroendocrine Tumours (NETs), Others), By End-User (Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI1832DR
Last Updated : Oct 10, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Radioligand Therapy Market, By Isotope (2021-2033)
    1. Lutetium-177 (Lu-177)
    2. Actinium-225 (Ac-225)
    3. Iodine-131 (I-131)
    4. Other Isotopes
  2. Radioligand Therapy Market, By Target (2021-2033)
    1. Prostate-Specific Membrane Antigen
    2. Ki 67 Expression and Grading
    3. Cytochrome P450 17A1 Inhibitor
  3. Radioligand Therapy Market, By Indication (2021-2033)
    1. Prostate Cancer
    2. Neuroendocrine Tumours (NETs)
    3. Others
  4. Radioligand Therapy Market, By End-User (2021-2033)
    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Cancer Treatment Centers
    4. Others
    1. North America
      1. North America Radioligand Therapy Market, By Isotope
        1. Lutetium-177 (Lu-177)
          1. Actinium-225 (Ac-225)
            1. Iodine-131 (I-131)
              1. Other Isotopes
              2. North America Radioligand Therapy Market, By Target
                1. Prostate-Specific Membrane Antigen
                  1. Ki 67 Expression and Grading
                    1. Cytochrome P450 17A1 Inhibitor
                    2. North America Radioligand Therapy Market, By Indication
                      1. Prostate Cancer
                        1. Neuroendocrine Tumours (NETs)
                          1. Others
                          2. North America Radioligand Therapy Market, By End-User
                            1. Hospitals
                              1. Ambulatory Surgical Centers
                                1. Cancer Treatment Centers
                                  1. Others
                                  2. U.S.
                                    1. U.S. Radioligand Therapy Market, By Isotope
                                      1. Lutetium-177 (Lu-177)
                                        1. Actinium-225 (Ac-225)
                                          1. Iodine-131 (I-131)
                                            1. Other Isotopes
                                            2. U.S. Radioligand Therapy Market, By Target
                                              1. Prostate-Specific Membrane Antigen
                                                1. Ki 67 Expression and Grading
                                                  1. Cytochrome P450 17A1 Inhibitor
                                                  2. U.S. Radioligand Therapy Market, By Indication
                                                    1. Prostate Cancer
                                                      1. Neuroendocrine Tumours (NETs)
                                                        1. Others
                                                        2. U.S. Radioligand Therapy Market, By End-User
                                                          1. Hospitals
                                                            1. Ambulatory Surgical Centers
                                                              1. Cancer Treatment Centers
                                                                1. Others
                                                              2. Canada
                                                            2. Europe
                                                              1. Europe Radioligand Therapy Market, By Isotope
                                                                1. Lutetium-177 (Lu-177)
                                                                  1. Actinium-225 (Ac-225)
                                                                    1. Iodine-131 (I-131)
                                                                      1. Other Isotopes
                                                                      2. Europe Radioligand Therapy Market, By Target
                                                                        1. Prostate-Specific Membrane Antigen
                                                                          1. Ki 67 Expression and Grading
                                                                            1. Cytochrome P450 17A1 Inhibitor
                                                                            2. Europe Radioligand Therapy Market, By Indication
                                                                              1. Prostate Cancer
                                                                                1. Neuroendocrine Tumours (NETs)
                                                                                  1. Others
                                                                                  2. Europe Radioligand Therapy Market, By End-User
                                                                                    1. Hospitals
                                                                                      1. Ambulatory Surgical Centers
                                                                                        1. Cancer Treatment Centers
                                                                                          1. Others
                                                                                          2. U.K.
                                                                                            1. U.K. Radioligand Therapy Market, By Isotope
                                                                                              1. Lutetium-177 (Lu-177)
                                                                                                1. Actinium-225 (Ac-225)
                                                                                                  1. Iodine-131 (I-131)
                                                                                                    1. Other Isotopes
                                                                                                    2. U.K. Radioligand Therapy Market, By Target
                                                                                                      1. Prostate-Specific Membrane Antigen
                                                                                                        1. Ki 67 Expression and Grading
                                                                                                          1. Cytochrome P450 17A1 Inhibitor
                                                                                                          2. U.K. Radioligand Therapy Market, By Indication
                                                                                                            1. Prostate Cancer
                                                                                                              1. Neuroendocrine Tumours (NETs)
                                                                                                                1. Others
                                                                                                                2. U.K. Radioligand Therapy Market, By End-User
                                                                                                                  1. Hospitals
                                                                                                                    1. Ambulatory Surgical Centers
                                                                                                                      1. Cancer Treatment Centers
                                                                                                                        1. Others
                                                                                                                      2. Germany
                                                                                                                      3. France
                                                                                                                      4. Spain
                                                                                                                      5. Italy
                                                                                                                      6. Russia
                                                                                                                      7. Nordic
                                                                                                                      8. Benelux
                                                                                                                      9. Rest of Europe
                                                                                                                    2. APAC
                                                                                                                      1. APAC Radioligand Therapy Market, By Isotope
                                                                                                                        1. Lutetium-177 (Lu-177)
                                                                                                                          1. Actinium-225 (Ac-225)
                                                                                                                            1. Iodine-131 (I-131)
                                                                                                                              1. Other Isotopes
                                                                                                                              2. APAC Radioligand Therapy Market, By Target
                                                                                                                                1. Prostate-Specific Membrane Antigen
                                                                                                                                  1. Ki 67 Expression and Grading
                                                                                                                                    1. Cytochrome P450 17A1 Inhibitor
                                                                                                                                    2. APAC Radioligand Therapy Market, By Indication
                                                                                                                                      1. Prostate Cancer
                                                                                                                                        1. Neuroendocrine Tumours (NETs)
                                                                                                                                          1. Others
                                                                                                                                          2. APAC Radioligand Therapy Market, By End-User
                                                                                                                                            1. Hospitals
                                                                                                                                              1. Ambulatory Surgical Centers
                                                                                                                                                1. Cancer Treatment Centers
                                                                                                                                                  1. Others
                                                                                                                                                  2. China
                                                                                                                                                    1. China Radioligand Therapy Market, By Isotope
                                                                                                                                                      1. Lutetium-177 (Lu-177)
                                                                                                                                                        1. Actinium-225 (Ac-225)
                                                                                                                                                          1. Iodine-131 (I-131)
                                                                                                                                                            1. Other Isotopes
                                                                                                                                                            2. China Radioligand Therapy Market, By Target
                                                                                                                                                              1. Prostate-Specific Membrane Antigen
                                                                                                                                                                1. Ki 67 Expression and Grading
                                                                                                                                                                  1. Cytochrome P450 17A1 Inhibitor
                                                                                                                                                                  2. China Radioligand Therapy Market, By Indication
                                                                                                                                                                    1. Prostate Cancer
                                                                                                                                                                      1. Neuroendocrine Tumours (NETs)
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. China Radioligand Therapy Market, By End-User
                                                                                                                                                                          1. Hospitals
                                                                                                                                                                            1. Ambulatory Surgical Centers
                                                                                                                                                                              1. Cancer Treatment Centers
                                                                                                                                                                                1. Others
                                                                                                                                                                              2. Korea
                                                                                                                                                                              3. Japan
                                                                                                                                                                              4. India
                                                                                                                                                                              5. Australia
                                                                                                                                                                              6. Taiwan
                                                                                                                                                                              7. South East Asia
                                                                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                              1. Middle East and Africa Radioligand Therapy Market, By Isotope
                                                                                                                                                                                1. Lutetium-177 (Lu-177)
                                                                                                                                                                                  1. Actinium-225 (Ac-225)
                                                                                                                                                                                    1. Iodine-131 (I-131)
                                                                                                                                                                                      1. Other Isotopes
                                                                                                                                                                                      2. Middle East and Africa Radioligand Therapy Market, By Target
                                                                                                                                                                                        1. Prostate-Specific Membrane Antigen
                                                                                                                                                                                          1. Ki 67 Expression and Grading
                                                                                                                                                                                            1. Cytochrome P450 17A1 Inhibitor
                                                                                                                                                                                            2. Middle East and Africa Radioligand Therapy Market, By Indication
                                                                                                                                                                                              1. Prostate Cancer
                                                                                                                                                                                                1. Neuroendocrine Tumours (NETs)
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. Middle East and Africa Radioligand Therapy Market, By End-User
                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                      1. Ambulatory Surgical Centers
                                                                                                                                                                                                        1. Cancer Treatment Centers
                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                          2. UAE
                                                                                                                                                                                                            1. UAE Radioligand Therapy Market, By Isotope
                                                                                                                                                                                                              1. Lutetium-177 (Lu-177)
                                                                                                                                                                                                                1. Actinium-225 (Ac-225)
                                                                                                                                                                                                                  1. Iodine-131 (I-131)
                                                                                                                                                                                                                    1. Other Isotopes
                                                                                                                                                                                                                    2. UAE Radioligand Therapy Market, By Target
                                                                                                                                                                                                                      1. Prostate-Specific Membrane Antigen
                                                                                                                                                                                                                        1. Ki 67 Expression and Grading
                                                                                                                                                                                                                          1. Cytochrome P450 17A1 Inhibitor
                                                                                                                                                                                                                          2. UAE Radioligand Therapy Market, By Indication
                                                                                                                                                                                                                            1. Prostate Cancer
                                                                                                                                                                                                                              1. Neuroendocrine Tumours (NETs)
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. UAE Radioligand Therapy Market, By End-User
                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                    1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                      1. Cancer Treatment Centers
                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                      1. LATAM Radioligand Therapy Market, By Isotope
                                                                                                                                                                                                                                        1. Lutetium-177 (Lu-177)
                                                                                                                                                                                                                                          1. Actinium-225 (Ac-225)
                                                                                                                                                                                                                                            1. Iodine-131 (I-131)
                                                                                                                                                                                                                                              1. Other Isotopes
                                                                                                                                                                                                                                              2. LATAM Radioligand Therapy Market, By Target
                                                                                                                                                                                                                                                1. Prostate-Specific Membrane Antigen
                                                                                                                                                                                                                                                  1. Ki 67 Expression and Grading
                                                                                                                                                                                                                                                    1. Cytochrome P450 17A1 Inhibitor
                                                                                                                                                                                                                                                    2. LATAM Radioligand Therapy Market, By Indication
                                                                                                                                                                                                                                                      1. Prostate Cancer
                                                                                                                                                                                                                                                        1. Neuroendocrine Tumours (NETs)
                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                          2. LATAM Radioligand Therapy Market, By End-User
                                                                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                                                                              1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                                                1. Cancer Treatment Centers
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. Brazil
                                                                                                                                                                                                                                                                    1. Brazil Radioligand Therapy Market, By Isotope
                                                                                                                                                                                                                                                                      1. Lutetium-177 (Lu-177)
                                                                                                                                                                                                                                                                        1. Actinium-225 (Ac-225)
                                                                                                                                                                                                                                                                          1. Iodine-131 (I-131)
                                                                                                                                                                                                                                                                            1. Other Isotopes
                                                                                                                                                                                                                                                                            2. Brazil Radioligand Therapy Market, By Target
                                                                                                                                                                                                                                                                              1. Prostate-Specific Membrane Antigen
                                                                                                                                                                                                                                                                                1. Ki 67 Expression and Grading
                                                                                                                                                                                                                                                                                  1. Cytochrome P450 17A1 Inhibitor
                                                                                                                                                                                                                                                                                  2. Brazil Radioligand Therapy Market, By Indication
                                                                                                                                                                                                                                                                                    1. Prostate Cancer
                                                                                                                                                                                                                                                                                      1. Neuroendocrine Tumours (NETs)
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                        2. Brazil Radioligand Therapy Market, By End-User
                                                                                                                                                                                                                                                                                          1. Hospitals
                                                                                                                                                                                                                                                                                            1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                                                                              1. Cancer Treatment Centers
                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                          Related Reports

                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                                          Buy Now

                                                                                                                                                                                                                                                                                          Purchase Benefits

                                                                                                                                                                                                                                                                                          • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                          • Completely customizable scope
                                                                                                                                                                                                                                                                                          • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                          • Dedicated account manager
                                                                                                                                                                                                                                                                                          • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                          • Permission to print the report

                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                          www.straitsresearch.com
                                                                                                                                                                                                                                                                                          © Copyright . All rights Reserved.